Latest & greatest articles for children

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on children or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on children and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for children

1. Household interventions for secondary prevention of domestic lead exposure in children. (Abstract)

-beneficial effect of the environmental intervention (e.g. mental development (Bayley Scales of Infant Development-II): MD 0.1, 95% CI -2.1 to 2.4; 1 study, 302 participants; low-certainty evidence). The same study did not observe any adverse events related to the intervention during the eight-year follow-up, but observed two children with adverse events in the control group (1 study, 355 participants; very low-certainty evidence). Meta-analysis also found no evidence of effectiveness on blood lead levels (...) Household interventions for secondary prevention of domestic lead exposure in children. Lead exposure is a serious health hazard, especially for children. It is associated with physical, cognitive and neurobehavioural impairment in children. There are many potential sources of lead in the environment, therefore trials have tested many household interventions to prevent or reduce lead exposure. This is an update of a previously published review.To assess the effects of household interventions

2020 Cochrane

2. Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. (Abstract)

Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. Evolocumab, a fully human monoclonal antibody directed against proprotein convertase subtilisin-kexin type 9, is widely used in adult patients to lower low-density lipoprotein (LDL) cholesterol levels. Its effects in pediatric patients with heterozygous familial hypercholesterolemia are not known.We conducted a 24-week, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of evolocumab (...) in pediatric patients with heterozygous familial hypercholesterolemia. Patients 10 to 17 years of age who had received stable lipid-lowering treatment for at least 4 weeks before screening and who had an LDL cholesterol level of 130 mg per deciliter (3.4 mmol per liter) or more and a triglyceride level of 400 mg per deciliter (4.5 mmol per liter) or less were randomly assigned in a 2:1 ratio to receive monthly subcutaneous injections of evolocumab (420 mg) or placebo. The primary end point was the percent

2020 NEJM

3. Advice on the use of masks for children in the community in the context of COVID-19

diseases will need to be specified. 4. The use of a medical mask for immunocompromised children or for paediatric patients with cystic fibrosis or certain other diseases (e.g. cancer) is usually recommended but should be assessed in consultation with the child’s medical provider 46,47 . a Defined by WHO as “experiencing larger outbreaks of local transmission defined through an assessment of factors including, but not limited to: large numbers of cases not linkable to transmission chains; large numbers (...) Kamadjeu, Sarah Karmin, Asma Maladwala, Ana Nieto, Luwei Pearson Sarah Karmin, Jerome Pfaffmann. 3. External reviewers: Susanna Esposito, World Association for Infectious Diseases and Immunological Disorders and University of Parma, Italy; Angela Dramowski, Stellenbosch University, South Africa; Alfredo Tagarro, Universidad Europea de Madrid, Spain. Reviewers from IPA: Zulfiqar A. Bhutta, Centre for Global Child Health, The Hospital for Sick Children, Canada; Margaret Fisher, Department of Pediatrics

2020 WHO Coronavirus disease (COVID-19) Pandemic

4. Paediatric deep brain stimulation

Paediatric deep brain stimulation Paediatric deep brain stimulation - Sax Institute - Sax Institute × Close Sign up for our newsletter Name Email * Position Centre Subscribe Paediatric deep brain stimulation The 45 and Up Study Learn more about our research into healthy ageing × The 45 and Up Study Paediatric deep brain stimulation (PDF 804 KB)

2020 Sax Institute Evidence Check

5. Survey instruments for monitoring self-esteem in children

Survey instruments for monitoring self-esteem in children Survey instruments for monitoring self-esteem in children - Sax Institute - Sax Institute × Close Sign up for our newsletter Name Email * Position Centre Subscribe Survey instruments for monitoring self-esteem in children The 45 and Up Study Learn more about our research into healthy ageing × The 45 and Up Study Survey instruments for monitoring self-esteem in children (PDF 2MB)

2020 Sax Institute Evidence Check

6. Ustekinumab for refractory Crohn’s disease in pre-pubescent children

Ustekinumab for refractory Crohn’s disease in pre-pubescent children NHS England » Ustekinumab for refractory Crohn’s disease in pre-pubescent children Cookies on the NHS England and NHS Improvement website We’ve put some small files called cookies on your device to make our site work. We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site. Let us know if this is OK. We’ll use (...) a cookie to save your choice. You can before you choose. Change my preferences I'm OK with analytics cookies Search Search Menu . If you are a member of the public looking for health advice, go to the . And if you are looking for the latest travel information, and advice about the government response to the outbreak, go to the . Ustekinumab for refractory Crohn’s disease in pre-pubescent children Document first published: 9 July 2020 Page updated: 22 July 2020 Topic: , , Publication type: , Document

2020 NHS England

7. Plerixafor for stem cell mobilisation in adults and children

Plerixafor for stem cell mobilisation in adults and children NHS England » Plerixafor for stem cell mobilisation in adults and children Cookies on the NHS England and NHS Improvement website We’ve put some small files called cookies on your device to make our site work. We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site. Let us know if this is OK. We’ll use a cookie to save (...) your choice. You can before you choose. Change my preferences I'm OK with analytics cookies Search Search Menu . If you are a member of the public looking for health advice, go to the . And if you are looking for the latest travel information, and advice about the government response to the outbreak, go to the . Plerixafor for stem cell mobilisation in adults and children Document first published: 24 September 2020 Page updated: 5 October 2020 Topic: Publication type: The policy is for plerixafor

2020 NHS England

8. Psychosocial support for families of children with neurodisability who have or are considering a gastrostomy: the G-PATH mixed-methods study Full Text available with Trip Pro

Psychosocial support for families of children with neurodisability who have or are considering a gastrostomy: the G-PATH mixed-methods study Psychosocial support for families of children with neurodisability who have or are considering a gastrostomy: the G-PATH mixed-methods study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from

2020 NIHR HTA programme

9. Behaviour change interventions to reduce risky substance use and improve mental health in children in care: the SOLID three-arm feasibility RCT Full Text available with Trip Pro

Behaviour change interventions to reduce risky substance use and improve mental health in children in care: the SOLID three-arm feasibility RCT Behaviour change interventions to reduce risky substance use and improve mental health in children in care: the SOLID three-arm feasibility RCT Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from (...) the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} In this study, only 20% of participants attended the interventions, and screening and recruitment of children required more time and resources than planned, so a full trial is not feasible. {{author}} {{($index , , , , , , , , , , & . Hayley Alderson 1 , Eileen Kaner 1, * , Rebecca Brown 1 , Denise Howel 1 , Elaine McColl 1

2020 NIHR HTA programme

10. Rituximab (MabThera) - for the treatment of paediatric patients with previously untreated advanced stage CD20 positive diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL)/Burkitt leukaemia (mature B-cell acute leukaemia) (BAL) or Burkitt-like lym

Rituximab (MabThera) - for the treatment of paediatric patients with previously untreated advanced stage CD20 positive diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL)/Burkitt leukaemia (mature B-cell acute leukaemia) (BAL) or Burkitt-like lym rituximab (MabThera®) - All Wales Medicines Strategy Group Opens in new window Cymraeg Search Search Cymraeg Menu Search › › › rituximab (MabThera®) Following non-submission AWMSG advice Status: Not endorsed (Statement of Advice (...) ) In the absence of a submission from the holder of the marketing authorisation, rituximab (MabThera®) cannot be endorsed for use within NHS Wales in combination with chemotherapy for the treatment of paediatric patients (aged ≥6 months to <18 years old) with previously untreated advanced stage CD20 positive diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL)/Burkitt leukaemia (mature B-cell acute leukaemia) (BAL) or Burkitt-like lymphoma (BLL). Medicine details Medicine name rituximab (MabThera®

2020 All Wales Medicines Strategy Group

11. P-COSCA (Pediatric Core Outcome Set for Cardiac Arrest) in Children: An Advisory Statement From the International Liaison Committee on Resuscitation Full Text available with Trip Pro

P-COSCA (Pediatric Core Outcome Set for Cardiac Arrest) in Children: An Advisory Statement From the International Liaison Committee on Resuscitation P-COSCA (Pediatric Core Outcome Set for Cardiac Arrest) in Children: An Advisory Statement From the International Liaison Committee on Resuscitation | Circulation Search Search Hello Guest! Login to your account Email Password Keep me logged in Search Search October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 (...) February 2020 January 2020 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access Review Article Share on Jump to Free Access Review Article P-COSCA (Pediatric Core Outcome Set for Cardiac Arrest) in Children: An Advisory Statement From the International Liaison Committee on Resuscitation , MD, MSCE, FAHA, Chair , MBBS, MRCPCH, PhD , MD, MS , MD, MS, FAHA , MD, PhD, Vice Chair , DPhil, BSc(Hons), PGCertHE , FRCPCH, FRCPI, FRCEM, PhD , MD, MS, FAHA

2020 American Heart Association

12. Vaccine recommendations for children and youth for the 2020/2021 influenza season

Vaccine recommendations for children and youth for the 2020/2021 influenza season The Canadian Paediatric Society continues to encourage annual influenza vaccination for ALL children and youth 6 months of age and older. Recommendations from the National Advisory Committee on Immunization (NACI) for the 2020/2021 influenza season are not substantially changed from those of last season except for permitting the use of live attenuated influenza vaccine in selected children with well-controlled HIV (...) infection. Quadrivalent vaccine, if available, is recommended for children 6 months to 17 years of age. Either inactivated influenza vaccine or live attenuated influenza vaccine may be used for children and youth 2 to 17 years of age who are not immunocompromised. LAIV will again be available in Canada for the 2020/2021 season. NACI has also addressed issues related to provision of influenza vaccine during the COVID-19 pandemic. Keywords:   Children; COVID-19; Influenza vaccine; Inactivated

2020 Canadian Paediatric Society

13. Bilateral ultrasound-guided thoracic erector spinae plane blocks using a programmed intermittent bolus improve opioid-sparing postoperative analgesia in pediatric patients after open cardiac surgery: a randomized, double-blind, placebo-controlled trial

Bilateral ultrasound-guided thoracic erector spinae plane blocks using a programmed intermittent bolus improve opioid-sparing postoperative analgesia in pediatric patients after open cardiac surgery: a randomized, double-blind, placebo-controlled trial Bilateral ultrasound-guided thoracic erector spinae plane blocks using a programmed intermittent bolus improve opioid-sparing postoperative analgesia in pediatric patients after open cardiac surgery: a randomized, double-blind, placebo-controlled (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Reg Anesth Pain Med Actions . 2020 Oct;45(10):805-812. doi: 10.1136/rapm-2020-101496. Epub 2020 Aug 19. Bilateral ultrasound-guided thoracic erector spinae plane blocks using a programmed intermittent bolus improve opioid-sparing postoperative analgesia in pediatric patients after open cardiac surgery: a randomized, double-blind, placebo-controlled trial

2020 EvidenceUpdates

14. Randomized trial of early infant formula introduction to prevent cow's milk allergy Full Text available with Trip Pro

allergy , , , , , Affiliations Expand Affiliations 1 Department of Pediatrics, Heartlife Hospital, Okinawa, Japan. Electronic address: odekorin2000@yahoo.co.jp. 2 Department of Pediatrics, Okinawa Kyodo Hospital, Okinawa, Japan. 3 Department of Pediatrics, Naha City Hospital, Okinawa, Japan. 4 Department of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan. 5 Department of Allergy, Aichi Children's Health and Medical Center, Aichi, Japan (...) Department of Pediatrics, Okinawa Kyodo Hospital, Okinawa, Japan. 3 Department of Pediatrics, Naha City Hospital, Okinawa, Japan. 4 Department of Child Health and Welfare (Pediatrics), Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan. 5 Department of Allergy, Aichi Children's Health and Medical Center, Aichi, Japan. PMID: 32890574 DOI: Item in Clipboard Full-text links Cite Display options Display options Format Abstract Background: Previous research has produced conflicting

2020 EvidenceUpdates

15. Effect of Clinician Training in the Modular Approach to Therapy for Children vs Usual Care on Clinical Outcomes and Use of Empirically Supported Treatments: A Randomized Clinical Trial Full Text available with Trip Pro

and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island. 8 Le Va, Harakeke House, Manukau, Auckland, New Zealand. 9 Infant, Child and Adolescent Mental Health Services, Waikato District Health Board, Hamilton, New Zealand. 10 Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. PMID: 32804212 PMCID: DOI: Free PMC article Item in Clipboard Effect of Clinician Training in the Modular Approach to Therapy (...) Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island. 8 Le Va, Harakeke House, Manukau, Auckland, New Zealand. 9 Infant, Child and Adolescent Mental Health Services, Waikato District Health Board, Hamilton, New Zealand. 10 Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. PMID: 32804212 PMCID: DOI: Item in Clipboard Full-text links Cite Display options Display options Format

2020 EvidenceUpdates

16. Early Postnatal Discharge for Infants: A Meta-analysis

Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Review Pediatrics Actions . 2020 Sep;146(3):e20193365. doi: 10.1542/peds.2019-3365. Early Postnatal Discharge for Infants: A Meta-analysis , , , , , Affiliations Expand Affiliations 1 Institute of Applied Health Research, University of Birmingham (...) , Birmingham, United Kingdom; and e.jones.10@bham.ac.uk. 2 Institute of Applied Health Research, University of Birmingham, Birmingham, United Kingdom; and. 3 Department of Nursing and Midwifery, Three Counties School of Nursing and Midwifery, College of Health, Life and Environmental Sciences, University of Worcester, Worcester, United Kingdom. PMID: 32826340 DOI: Item in Clipboard Review Early Postnatal Discharge for Infants: A Meta-analysis Eleanor Jones et al. Pediatrics . 2020 Sep . Show details

2020 EvidenceUpdates

17. Child life Therapy Burn Patient Management

practice in paediatric occupational therapy: A review of the literature on parent-therapist collaboration. Australian Occupational Therapy Journal, 2002;49:14-24. doi:10.1046/j.0045-0766.2001.00273.x. 7. Hollon, E., & Skinner, L. Assessment and documentation in child life. In R. H. Thompson (Ed.), The handbook of child life: A guide to pediatric psychosocial care. Illinois, USA: Charles C Thomas Publisher, LTD. 2009. p. 116-135. 8. Kids Matter. Play helps children feel good about themselves. Available (...) Developmental play 12 Family-centred practice 13 Required documentation 14 Professional development 15 Associations 15 Journals 15 Occupational health and safety 16 Infection control 16 References 17 Appendix 1. Assessment guide 18 Statewide Burn Injury Service | Child life therapy Burn patient management 3 Introduction Paediatric health conditions and hospitalisation cause stress and anxiety for children and their families. Child life therapy is an allied health profession that focuses on supporting

2020 Agency for Clinical Innovation

18. COVID-19 in children and the role of school settings in COVID-19 transmission

understand infection and antibody dynamics. Investigations of cases identified in school settings suggest that child to child transmission in schools is uncommon and not the primary cause of SARS-CoV-2 infection in children whose onset of infection coincides with the period during which they are attending school, particularly in preschools and primary schools. If appropriate physical distancing and hygiene measures are applied, schools are unlikely to be more effective propagating environments than other (...) Technical report 6 Aug 2020 Cite: COVID-19 in children and the role of school settings in COVID-19 transmission, 6 August 2020. Stockholm: ECDC; 2020. The aim of this document is to provide an overview of the epidemiology and disease characteristics of COVID-19 in children (0-18 years) in EU/EEA countries and the United Kingdom (UK), and an assessment of the role of childcare (preschools; ages 0-<5 years) and educational (primary and secondary schools; ages 5-18 years) settings in COVID-19 transmission

2020 European Centre for Disease Prevention and Control - Technical Guidance

19. COVID-19: guidance on supporting children and young people’s mental health and wellbeing

COVID-19: guidance on supporting children and young people’s mental health and wellbeing COVID-19: guidance on supporting children and young people’s mental health and wellbeing - GOV.UK Tell us whether you accept cookies We use about how you use GOV.UK. We use this information to make the website work as well as possible and improve government services. Accept all cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance and support Part of Guidance COVID-19: guidance (...) on supporting children and young people’s mental health and wellbeing Advice for parents and carers on looking after the mental health and wellbeing of children or young people during the coronavirus (COVID-19) outbreak. Published 29 March 2020 Last updated 14 September 2020 — From: Documents HTML Ref: PHE publications gateway number GW-1212 . Please tell us what format you need. It will help us if you say what assistive technology you use. . Please tell us what format you need. It will help us if you say

2020 Public Health England

20. Flu immunisation for early years settings including child minders

in the General Election on 12 December. Guidance Flu immunisation for early years settings including child minders Guidance for early years childcare settings on the nasal spray flu (influenza) vaccination for preschool children. Published 16 September 2016 Last updated 15 October 2019 — From: Documents Ref: PHE Publications Gateway Number 2019074 15 October 2019 Added pre-school guidance for the 2019 to 2020 flu season. 18 September 2018 Added revised guidance for early years childcare settings. 7 September (...) Flu immunisation for early years settings including child minders Flu immunisation for early years settings including child minders - GOV.UK GOV.UK uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve government digital services. Any data collected is anonymised. By continuing to use this site, you agree to our use of cookies. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Register by 26 November to vote

2020 Public Health England